Waystar Considers Strategic Options, Including Potential Sale
Waystar is exploring a possible sale, returning it to private ownership, amid a 24% share price drop.
Healthcare software company Waystar is exploring strategic options, including a potential sale, according to sources familiar with the matter. This move comes just two years after its public listing in New York. The software provider, whose technology aids hospitals and doctors in managing payments, has seen its market value decline to approximately $4.8 billion following a 24% drop in its share price this year.
Waystar's Strategic Shift
Waystar, headquartered in Lehi, Utah, and Louisville, Kentucky, has engaged investment bank Evercore to guide the process. The company's efforts to reposition itself as a technology firm, rather than a services-focused business, aimed to capitalize on higher valuations typically enjoyed by tech companies. However, the stock has faced challenges, partly due to investor concerns about potential disruptions from advancements in artificial intelligence, as noted by Morgan Stanley analysts.
Ownership and Financial Background
Formed in 2017 through the merger of Zirmed and Navicure, Waystar's largest shareholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and BlackRock Institutional Trust Company. EQT holds a 13% stake, while CPPIB and BlackRock own 10% and 8%, respectively. The company went public in 2024, driven by backing from these major investors.
The current exploration of options, which could potentially result in an auction process, aims to assess investor interest in the software sector. Despite the initial enthusiasm following its stock market debut, Waystar's shares have not sustained their peak value of $45 reached in 2025, dropping to $20 amid broader market challenges.
Market Response and Future Prospects
The potential sale of Waystar could mark a significant change for the company, as it seeks to navigate a volatile market environment. While the company's representatives declined to comment, the outcome of this strategic exploration remains uncertain. The possibility of returning to private ownership could provide Waystar with the flexibility needed to adapt to the evolving healthcare technology landscape.